08.07.2016 - Within the course of a week, US-based KaloBios Pharmaceuticals has emerged from Chapter 11 bankruptcy protection, renegotiated a deal to acquire rights to a new developmental drug...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)